Biobohemia, Inc. is a preclinical biotechnology company focused on development of cancer vaccines. Our proprietary cell Antigenic Essence
technology is behind the development of cancer vaccines against virtually any solid cancer. The company is progressing the development of both therapeutic and prevention vaccines. SANTAVACTM
— main Antigenic Essence product of our company. It carries desired antigenic properties of the entire cell while only occupying 1% of the cell content. Its composition is encoded by mass spectrometry for the precise targeting of solid tumors. SANTAVACTM
enables targeted destruction of tumor vessels' endothelial cells, which leads to tumor vascular obstruction, disrupts tumor feeding and arrests tumor growth.